A world leader in the development and commercialization of innovative Light Accelerated Orthodontic products.

Cyteir Therapeutics

Leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases.


The first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.


Inscripta offers the world’s first benchtop platform for scalable Digital Genome Engineering to address the current challenges and limitations of gene editing.